Global Healthcare Study on Psoriasis

Abroad (travel likely)Recruiting

Conditions

Psoriasis (PsO)

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

University of Zurich, Zurich, Switzerland
Contact: Study coordinator (Julia-Tatjana Maul) · julia-tatjana.maul@uzh.ch · +41 76 441 51 09

Study leads

Julia-Tatjana Maul, Prof. Dr. med.
Principal Investigator
University of Zurich

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

PPD™ CorEvitas™ Psoriasis (PSO) Early Treatment Response Non-Interventional Study

Psoriasis

Abroad (travel likely)Recruiting

Waltham, United States · Waltham, United States

A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)

Psoriasis · Overweight or Obesity

Abroad (travel likely)RecruitingPHASE4

Phoenix, United States · Fountain Valley, United States

Study of S-4321 in Participants With an Autoimmune or Immune-mediated Disease

Autoimmune Diseases · Rheumatoid Arthritis (RA) · Psoriatic Arthritis (PsA)

Abroad (travel likely)RecruitingPHASE1

Charlestown, Australia · Birtinya, Australia

PPD™ CorEvitas™ Psoriasis (PSO) Rapid Response Non-Interventional Study

Psoriasis

Abroad (travel likely)Recruiting

Waltham, United States